Advertisement Haemonetics acquires Neoteric Technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Haemonetics acquires Neoteric Technology

Haemonetics, a blood management solutions company, has acquired Neoteric Technology, a medical information management company.

Neoteric’s products will be integrated into Haemonetics’s patient division for marketing and sales. The company’s operations will remain in Vancouver, British Columbia and the UK. Natixis Bleichroeder acted as a strategic advisor to Neoteric Technology.

The acquisition is expected to be neutral to earnings for Haemonetics in the first year and accretive thereafter. Terms of the deal were not disclosed.

Brian Concannon, president and CEO of Haemonetics, said: “We are pleased to be adding the Neoteric product offering to Haemonetics’s blood management solutions portfolio, which currently includes devices, software applications, and consulting services. These solutions will enable us to deliver a more complete blood management solution to the hospital market. The Neoteric blood tracking system reduces costs while improving patient care and optimizing blood management practice.”